The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent
Authors
Keywords
Sodium cromolyn, Blood vessels, Tumor cells, Chorioallantoic membrane
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 64, Issue 6, Pages 515-522
Publisher
Springer Nature
Online
2016-06-11
DOI
10.1007/s00005-016-0408-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor–Dependent Signaling
- (2016) Christopher Johnson et al. AMERICAN JOURNAL OF PATHOLOGY
- Mast cell stabilisers
- (2016) Tao Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tryptase, a novel angiogenic factor stored in mast cell granules
- (2015) Domenico Ribatti et al. EXPERIMENTAL CELL RESEARCH
- Emerging drugs for allergic conjunctivitis
- (2014) Erminia Ridolo et al. EXPERT OPINION ON EMERGING DRUGS
- Cromolyn ameliorates acute and chronic injury in a rat lung transplant model
- (2014) Jui-Chih Chang et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pharmacotherapy for allergic rhinitis
- (2014) Michael Platt International Forum of Allergy & Rhinology
- Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
- (2014) Michele Ammendola et al. Biomed Research International
- Twenty-first century mast cell stabilizers
- (2013) D F Finn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immunomodulators for conjunctivitis
- (2013) Punchama Pacharn et al. Current Opinion in Allergy and Clinical Immunology
- Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3
- (2013) Tarek M. K. Motawi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
- (2013) T. Arumugam et al. MOLECULAR CANCER THERAPEUTICS
- Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans
- (2012) Zuyi Weng et al. PLoS One
- The actual role of sodium cromoglycate in the treatment of asthma—a critical review
- (2012) Nikolaus C. Netzer et al. Sleep and Breathing
- Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension
- (2011) Beatrijs Bartelds et al. CHEST
- In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer
- (2011) Cha-Eun Kim et al. JOURNAL OF CONTROLLED RELEASE
- Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition
- (2011) Yuki Fujiwara et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Cromoglycate, reproterol, or both—what’s best for exercise-induced asthma?
- (2011) T. Küpper et al. Sleep and Breathing
- Antiallergic Cromones Inhibit Neutrophil Recruitment Onto Vascular Endothelium via Annexin-A1 Mobilization
- (2010) Samia Yazid et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mast cells have a protumorigenic role in human thyroid cancer
- (2010) R M Melillo et al. ONCOGENE
- G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium
- (2010) Yuhua Yang et al. PHARMACOLOGY
- Mast Cells and Pancreatic Cancer
- (2008) Theoharis C. Theoharides NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started